Drug Profile
Research programme: ROR gammaT antagonists - Immunic
Alternative Names: IMU-366Latest Information Update: 03 Oct 2023
Price :
$50
*
At a glance
- Originator 4SC
- Developer Immunic
- Class Anti-inflammatories; Antipsoriatics; Small molecules
- Mechanism of Action Nuclear receptor subfamily 1 group F member 3 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Autoimmune disorders; Immunological disorders; Inflammatory bowel diseases; Psoriasis